ASAnil A. Shah

Anil A. Shah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anil A. Shah has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Mingjing He

    Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA; State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, PR China

    3 shared publications
  • Yong Wan

    Department of Pharmacology and Chemical Biology Emory University School of Medicine Atlanta GA 30322 USA

    3 shared publications
  • Zhuan Zhou

    Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA

    3 shared publications
  • Qianming Chen

    Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Hangzhou, China

    2 shared publications
  • Rishabh Matta

    Division of Vascular Surgery, Department of Thoracic and Cardiovascular surgery, Allegheny Health Network, Pittsburgh, PA, USA

    2 shared publications
  • Satish Muluk

    Division of Vascular Surgery, Department of Thoracic and Cardiovascular surgery, Allegheny Health Network, Pittsburgh, PA, USA

    2 shared publications

Latest Publications

  • Case Report: Treatment of Transplanted Renal Artery Anastomotic Pseudoaneurysm With Parallel Stent Grafting

    by Anil Shah, Rishabh Matta, Isabel Billiar, Satish Muluk

    A 53 year old woman needed surgical management of an anastomotic pseudoaneurysm after renal transplant. Contrast enhanced computed tomography demonstrated a pseudoaneurysm arising off of the right external iliac artery. Considering the risk of potentially sacrificing her renal transplant, we elected to perform endovascular repair with parallel stent grafting. The operation was successful and postoperative course uneventful illustrating that this approach may be beneficial in similar circumstances.

  • Case Report: Successful Treatment of Aberrant Left Subclavian Artery With a Right-Sided Aortic Arch

    by Rishabh Matta, Anil Shah, Harmanpreet Bandesha, Shruthi Thiagarajasubramanian, Satish Muluk

    Right sided aortic arches with concomitant aberrant left subclavian arteries are exceedingly rare anatomical variants. We present a case of a 45 year old male that presented with symptoms consistent with dysphagia and known right sided aortic arch with an aberrant left subclavian artery. Though previous reports of repair have indeed been reported, we confirm that a hybrid approach to these anatomic variants remain feasible and with symptom resolution for patients.

  • Open Access

    The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics

    by Mingjing He, Zhuan Zhou, Anil A. Shah, Haojing Zou, Jin Tao, Qianming Chen, Yong Wan

    The addition of mono-ubiquitin or poly-ubiquitin chain to signaling proteins in response to DNA damage signal is thought to be a critical event that facilitates the recognition of DNA damage lesion site, the activation of checkpoint function, termination and checkpoint response and the recruitment of DNA repair proteins. Despite the ubiquitin modifiers, removal of ubiquitin from the functional proteins by the deubiquitinating enzymes (DUBs) plays an important role in orchestrating DNA damage response as well as DNA repair processes. Deregulated ubiquitination and deubiquitination could lead to genome instability that in turn causes tumorigenesis. Recent TCGA study has further revealed the connection between mutations in alteration of DUBs and various types of tumors. In addition, emerging drug design based on DUBs provides a new avenue for anti-cancer therapy. In this review, we will summarize the role of deubiquitination and specificity of DUBs, and highlight the recent discoveries of DUBs in the modulation of ubiquitin-mediated DNA damage response and DNA damage repair. We will furthermore discuss the DUBs involved in the tumorigenesis as well as interception of deubiquitination as a novel strategy for anti-cancer therapy.


  • Open Access

    New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics

    by Mingjing He, Zhuan Zhou, Anil A. Shah, Yang Hong, Qianming Chen, Yong Wan

    PTMs (posttranslational modifications) such as ubiquitylation, sumoylation, acetylation and protein methylation are pivotal modifiers that determine the activation, deactivation or subcellular localization of signaling proteins, facilitating the initiation, amplification and transduction of signaling. Accumulating evidence suggest that several key signaling molecules in Hippo signaling pathway are tightly regulated by various types of PTMs. Malfunction of these critical signaling modules such as YAP/TAZ, MAT1/2 and LATS1/2 due to deregulated PTMs has been linked to a variety of human diseases such as cancer. In this review article, we summarized the current understanding of the impact of PTMs in regulating Hippo signaling pathway and further discussed the potential therapeutic intervention from the view of PTMs and Hippo pathway.


  • Open Access

    Insights into APC/C: from cellular function to diseases and therapeutics

    by Zhuan Zhou, Mingjing He, Anil A. Shah, Yong Wan

    Anaphase-promoting complex/cyclosome (APC/C) is a multifunctional ubiquitin-protein ligase that targets different substrates for ubiquitylation and therefore regulates a variety of cellular processes such as cell division, differentiation, genome stability, energy metabolism, cell death, autophagy as well as carcinogenesis. Activity of APC/C is principally governed by two WD-40 domain proteins, Cdc20 and Cdh1, in and beyond cell cycle. In the past decade, the results based on numerous biochemical, 3D structural, mouse genetic and small molecule inhibitor studies have largely attracted our attention into the emerging role of APC/C and its regulation in biological function, human diseases and potential therapeutics. This review will aim to summarize some recently reported insights into APC/C in regulating cellular function, connection of its dysfunction with human diseases and its implication of therapeutics.